Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64876 - 64900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	CDK1	983	downregulated	resveratrol results in decreased expression of CDK1 mRNA	10q21.2	A23857 A22121
Resveratrol	Investigational	CDK1	983	upregulated	resveratrol results in increased expression of CDK1 mRNA	10q21.2	A21103
Resveratrol	Investigational	CDK2	1017	downregulated	resveratrol results in decreased expression of CDK2 mRNA	12q13.2	A22121
Resveratrol	Investigational	CDK4	1019	downregulated	resveratrol results in decreased expression of CDK4 mRNA	12q14.1	A23847
Resveratrol	Investigational	CDK5RAP2	55755	upregulated	resveratrol results in increased expression of CDK5RAP2 mRNA	9q33.2	A23845
Resveratrol	Investigational	CDK6	1021	downregulated	resveratrol results in decreased expression of CDK6 mRNA	7q21.2	A23856
Resveratrol	Investigational	CDK8	1024	upregulated	resveratrol results in increased expression of CDK8 mRNA	13q12.13	A21310
Resveratrol	Investigational	CDKN1A	1026	downregulated	resveratrol results in decreased expression of CDKN1A mRNA	6p21.2	A21103
Resveratrol	Investigational	CDKN1A	1026	upregulated	[resveratrol results in increased expression of and results in increased phosphorylation of TP53 protein] which results in increased expression of CDKN1A mRNA	6p21.2	A23899
Resveratrol	Investigational	CDKN1A	1026	upregulated	resveratrol results in increased expression of CDKN1A mRNA	6p21.2	A23899 A23900 A20482 A23901 A23885 A23902 A23895 A23903 A23872 A23904 A23858 A21310 A21623 A23845 A23867 A22435
Resveratrol	Investigational	CDKN1B	1027	upregulated	resveratrol results in increased expression of CDKN1B mRNA	12p13.1	A23895 A23858
Resveratrol	Investigational	CDKN1C	1028	upregulated	resveratrol results in increased expression of CDKN1C mRNA	11p15.4	A23847 A23876
Resveratrol	Investigational	CDKN2A	1029	downregulated	resveratrol results in decreased expression of CDKN2A mRNA	9p21.3	A23905
Resveratrol	Investigational	CDKN2B	1030	upregulated	resveratrol results in increased expression of CDKN2B mRNA	9p21.3	A23852
Resveratrol	Investigational	CDKN3	1033	upregulated	resveratrol results in increased expression of CDKN3 mRNA	14q22.2	A21103
Resveratrol	Investigational	CDX1	1044	downregulated	resveratrol results in decreased expression of CDX1 mRNA	5q32	A23876
Resveratrol	Investigational	CEACAM1	634	upregulated	resveratrol results in increased expression of CEACAM1 mRNA	19q13.2	A23859 A23852
Resveratrol	Investigational	CEBPD	1052	downregulated	resveratrol results in decreased expression of CEBPD mRNA	8q11.21	A23859
Resveratrol	Investigational	CEBPD	1052	upregulated	resveratrol results in increased expression of CEBPD mRNA	8q11.21	A22289
Resveratrol	Investigational	CENPE	1062	downregulated	resveratrol results in decreased expression of CENPE mRNA	4q24	A23857
Resveratrol	Investigational	CENPF	1063	downregulated	resveratrol results in decreased expression of CENPF mRNA	1q41	A23857
Resveratrol	Investigational	CENPM	79019	upregulated	resveratrol results in increased expression of CENPM mRNA	22q13.2	A21103
Resveratrol	Investigational	CEP152	22995	upregulated	resveratrol results in increased expression of CEP152 mRNA	15q21.1	A21103
Resveratrol	Investigational	CEP57	9702	upregulated	resveratrol results in increased expression of CEP57 mRNA	11q21	A21103
Resveratrol	Investigational	CERS1	10715	upregulated	resveratrol results in increased expression of CERS1 mRNA	19p13.11	A23906

Displaying entries 64876 - 64900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability